NIH wants to end bad data

Share this article:

The NIH is cracking down on bad data. The US agency announced in Nature that the research field is plagued by data that cannot be replicated, and points the finger not at fraud, but at poor training and the wrong publishing incentives, among other factors.

To correct this problem, the NIH said it is developing training modules that should increase “reproducibility and transparency of research findings.” The NIH also wants to put pressure on academic institutions to demand more of research, and says the current focus on big-name journals and budgetary pressures “encourages rapid submission of research findings to the detriment of careful replication” and says it may rework its NIH grant applications to better define the role each applicant played in the study, among other changes.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.